ClinicalTrials.gg
CompletedNCT04944745MTRFUpdated Mar 7, 2022

Myofascial Release of the Pectoral Fascia

An interventional study of Myofascial Release and Soft-touch Control in Healthy, sponsored by University of Manitoba. Completed at 1 site in Canada. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-07.

Sponsored by University of Manitoba · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Oct 2020, registered Jun 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Neck-shoulder pain is among the most common health care problems, especially in office workers and females. Forward shoulder posture (FSP) is a common postural deviation and known risk factor for the development of neck-shoulder pain and pathology. Common approaches for reducing FSP include stretching and performing manual techniques to increase the length and extensibility of the scapular protractors, and strengthening the scapular retractors. Myofascial release (MFR) is a group of manual techniques that elongate and soften restricted fascia, however, the effects of myofascial release to the pectorals on FSP are currently unknown. The objectives of this study are to determine the impact of 4-minutes of MFR on: 1) FSP, 2) pectoral length, 3) muscle activity of the upper, middle, and lower trapezius and pectoralis major, 4) scapular retractor to protractor ratio of activity, and 4) movement performance compared to a soft-touch control. We hypothesize that MFR will: 1) decrease FSP, 2) increase pectoral length, 3) increase upper, middle, and lower trapezius activity and decrease pectorals major activity, 4) increase the scapular retractor to protractor ratio of activity, and 4) improve movement performance.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

University of Manitoba is the lead sponsor of 554 studies on the registry; 88 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • have 1 cm of anterior deviation of the acromion process (forward shoulder posture)
  • right handed

Exclusion criteria

Exclusion Criteria:

  • recent history (\<6 months) of neck, shoulder, or upper back pain
  • recent history (\<6 months) of neck, shoulder, or upper back injury/pathology
  • history of orthopaedic or neurological disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Myofascial release (MFR)

    The pectoral MFR will be completed by an experienced registered massage therapist (RMT). They will stand on the participant's right side slightly rotated to the left facing towards the participant's left hip and apply a cross-hand MFR technique to the superficial pectoral fascia on the right side. The therapist will begin by placing the distal region of the anterior palm of the anchoring hand (therapist's right hand) on the right edge of the anterior sternum at the level of the 3rd to the 6th ribs on the skin and the draping over the pectoral fascia. They will then apply a gentle posterior pressure to hold the fascia in place. The forearm of the mobilizing hand (RMT's left hand) will be directed to the right shoulder wit hate right forearm crossing over the left and the contact of are of the mobilizing hand will be the skin superficial to the pectoral fascia and insertion of pectorals major on the anterior aspect of the humerus. This will be held for four minutes.

    Other: Myofascial Release

  • Sham comparator
    Soft-touch Control (CON)

    This control treatment will be set up the same way in regards to the RMT's hand placement, except no pressure will be applied. The RMT's hands will simply be resting over the contact points. This treatment will also be held for four minutes.

    Other: Soft-touch Control

Interventions

  • OtherMyofascial Release

    Moderate pressure manual treatment to the pectoral fascia.

  • OtherSoft-touch Control

    No pressure manual treatment to the pectoral fascia.

06

What researchers measure

Primary outcomes

  1. Change in Forward shoulder posture after intervention

    Relative- photographic analysis. Participant stand in a relaxed position and have a photo taken from their side where an online program will be used to quantify their forward shoulder posture

    Time frame: 30-minutes

  2. Change in Forward shoulder posture after intervention

    Absolute measurements taken- double square method. Participants will stand with their back against the wall and the tool will measure the distance from the wall to their acromion process.

    Time frame: 30-minutes

  3. Change in Pectoral Length after intervention

    Measured passive horizontal abduction of the shoulder

    Time frame: 30-minutes

  4. Change in Muscle Activity- Upper Trapezius after intervention

    sEMG during a reaching task

    Time frame: 30-minutes

  5. Change in Muscle Activity- Middle Trapezius after intervention

    sEMG during a reaching task

    Time frame: 30-minutes

  6. Change in Muscle Activity- Lower Trapezius after intervention

    sEMG during a reaching task

    Time frame: 30-minutes

  7. Change in Muscle Activity- Pectoralis Major after intervention

    sEMG during a reaching task

    Time frame: 30-minutes

  8. Change in Movement performance- reaction time after intervention

    Participants will complete a reaching task using custom designed software (E-Prime). The reaching task is a modified Fitts' Task where the participant must reach towards one of five randomly appearing targets.

    Time frame: 30-minutes

  9. Change in Movement performance- movement time after intervention

    Participants will complete a reaching task using custom designed software (E-Prime). The reaching task is a modified Fitts' Task where the participant must reach towards one of five randomly appearing targets.

    Time frame: 30-minutes

  10. Change in Movement performance- accuracy after intervention

    Participants will complete a reaching task using custom designed software (E-Prime). The reaching task is a modified Fitts' Task where the participant must reach towards one of five randomly appearing targets.

    Time frame: 30-minutes

07

Study locations

1 site
  • University of Manitoba
    Winnipeg, Manitoba R3T2N2, Canada
08

References and documents

Publications

  • Chimera NJ, Bohunicky S, Glazebrook C, Scribbans T. Postural factors contributing to reaching speed and accuracy. Int J Occup Saf Ergon. 2025 Sep;31(3):903-912. doi: 10.1080/10803548.2025.2466919. Epub 2025 Mar 10. PubMed 40062388 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04944745
Collaborators
Centennial College
Responsible party
Trisha Scribbans (Assistant Professor, University of Manitoba) — Principal investigator
First posted
Jun 30, 2021
Start date
Oct 14, 2020
Primary completion
Nov 6, 2021
Completion
Nov 6, 2021
Last update
Mar 7, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion